Thomas Arnhold

607 total citations
17 papers, 452 citations indexed

About

Thomas Arnhold is a scholar working on Molecular Biology, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, Thomas Arnhold has authored 17 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Computational Theory and Mathematics and 6 papers in Pharmacology. Recurrent topics in Thomas Arnhold's work include Analytical Chemistry and Chromatography (6 papers), Computational Drug Discovery Methods (6 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Thomas Arnhold is often cited by papers focused on Analytical Chemistry and Chromatography (6 papers), Computational Drug Discovery Methods (6 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Thomas Arnhold collaborates with scholars based in Germany, United States and Sweden. Thomas Arnhold's co-authors include Heinz Nau, Silke Meyer, Alfonso Lampen, Thomas Fox, Jan M. Kriegl, Bernd Beck, Andreas H. Luippold, Roderich D. Süßmuth, Georg Tzimas and W. Wittfoht and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Nutrition and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Thomas Arnhold

14 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Arnhold Germany 10 250 117 96 88 88 17 452
Masashi Hyuga Japan 17 519 2.1× 29 0.2× 113 1.2× 154 1.8× 31 0.4× 48 950
Sebastiaan van Liempd Spain 14 314 1.3× 47 0.4× 90 0.9× 84 1.0× 32 0.4× 21 500
Alfons Nonell‐Canals Spain 14 258 1.0× 66 0.6× 27 0.3× 21 0.2× 24 0.3× 20 599
Hua‐Li Zuo China 14 261 1.0× 55 0.5× 34 0.4× 106 1.2× 19 0.2× 40 582
Rupesh P. Amin United States 10 434 1.7× 87 0.7× 8 0.1× 79 0.9× 35 0.4× 17 736
Zeqiang Ma United States 17 495 2.0× 48 0.4× 191 2.0× 10 0.1× 36 0.4× 35 746
Hong Ji China 14 272 1.1× 48 0.4× 14 0.1× 94 1.1× 22 0.3× 29 508
Nicolas Gerst United States 14 320 1.3× 38 0.3× 45 0.5× 60 0.7× 24 0.3× 26 482
Ashraf G. Madian United States 8 327 1.3× 11 0.1× 109 1.1× 25 0.3× 40 0.5× 11 523

Countries citing papers authored by Thomas Arnhold

Since Specialization
Citations

This map shows the geographic impact of Thomas Arnhold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Arnhold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Arnhold more than expected).

Fields of papers citing papers by Thomas Arnhold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Arnhold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Arnhold. The network helps show where Thomas Arnhold may publish in the future.

Co-authorship network of co-authors of Thomas Arnhold

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Arnhold. A scholar is included among the top collaborators of Thomas Arnhold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Arnhold. Thomas Arnhold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Haertter, Sebastian, et al.. (2025). New Insights Into Hepatic Impairment (HI) Trials. Clinical and Translational Science. 18(1). e70130–e70130.
2.
3.
Stopfer, Peter, Ralf Lotz, Stefan Scheuerer, et al.. (2024). Beyond CL and VSS: A comprehensive approach to human pharmacokinetic predictions. Drug Discovery Today. 29(12). 104238–104238. 2 indexed citations
4.
Tourneau, Christophe Le, Rainer Claus, Francesco Ricci, et al.. (2018). First-in-human phase I trial of BI 836880, a vascular endothelial growth factor (VEGF)/angiopoietin-2 (Ang-2)-blocking nanobody, given every 3 weeks (q3w) in patients (pts) with advanced/metastatic solid tumors.. Journal of Clinical Oncology. 36(15_suppl). 12024–12024. 5 indexed citations
5.
Tourneau, Christophe Le, Josep Tabernero, Rainer Claus, et al.. (2018). PK/PD properties of BI 836880, a vascular endothelial growth factor (VEGF)/angiopoietin-2 (Ang-2)-blocking nanobody, in patients (pts) with advanced/metastatic solid tumors.. Journal of Clinical Oncology. 36(15_suppl). 2523–2523. 1 indexed citations
6.
7.
Luippold, Andreas H., et al.. (2010). An integrated platform for fully automated high-throughput LC–MS/MS analysis of in vitro metabolic stability assay samples. International Journal of Mass Spectrometry. 296(1-3). 1–9. 35 indexed citations
8.
Kriegl, Jan M., Thomas Arnhold, Bernd Beck, & Thomas Fox. (2005). A support vector machine approach to classify human cytochrome P450 3A4 inhibitors. Journal of Computer-Aided Molecular Design. 19(3). 189–201. 49 indexed citations
9.
Kriegl, Jan M., Lennart Eriksson, Thomas Arnhold, et al.. (2005). Multivariate modeling of cytochrome P450 3A4 inhibition. European Journal of Pharmaceutical Sciences. 24(5). 451–463. 27 indexed citations
10.
Kriegl, Jan M., Thomas Arnhold, Bernd Beck, & Thomas Fox. (2005). Prediction of Human Cytochrome P450 Inhibition Using Support Vector Machines. QSAR & Combinatorial Science. 24(4). 491–502. 27 indexed citations
11.
Eriksson, Lennart, Thomas Arnhold, Bernd Beck, et al.. (2004). Onion design and its application to a pharmaceutical QSAR problem. Journal of Chemometrics. 18(3-4). 188–202. 24 indexed citations
12.
Santos‐Guzmán, Jesús, Gloria E. Mao, Marian E. Swendseid, et al.. (2003). Antagonism of Hypervitaminosis A-Induced Anterior Neural Tube Closure Defects with a Methyl-Donor Deficiency in Murine Whole-Embryo Culture. Journal of Nutrition. 133(11). 3561–3570. 9 indexed citations
13.
14.
Arnhold, Thomas, et al.. (2002). Porcine Intestinal Metabolism of Excess Vitamin A Differs Following Vitamin A Supplementation and Liver Consumption. Journal of Nutrition. 132(2). 197–203. 13 indexed citations
15.
Lampen, Alfonso, Silke Meyer, Thomas Arnhold, & Heinz Nau. (2000). Metabolism of Vitamin A and Its Active Metabolite All-trans-retinoic Acid in Small Intestinal Enterocytes. Journal of Pharmacology and Experimental Therapeutics. 295(3). 979–985. 127 indexed citations
16.
Arnhold, Thomas, et al.. (1996). Identification of 9-cis-retinoic acid, 9,13-di-cis-retinoic acid, and 14-hydroxy-4,14-retro-retinol in human plasma after liver consumption. Life Sciences. 59(12). PL169–PL177. 63 indexed citations
17.
Arnhold, Thomas, et al.. (1989). Sprechwissenschaft & Psycholinguistik 3. VS Verlag für Sozialwissenschaften eBooks.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masashi Hyuga Breakdown of academic impact, for papers by Sebastiaan van Liempd Breakdown of academic impact, for papers by Alfons Nonell‐Canals Breakdown of academic impact, for papers by Hua‐Li Zuo Breakdown of academic impact, for papers by Rupesh P. Amin Breakdown of academic impact, for papers by Zeqiang Ma Breakdown of academic impact, for papers by Hong Ji Breakdown of academic impact, for papers by Nicolas Gerst Breakdown of academic impact, for papers by Ashraf G. Madian
Rankless by CCL
2026